InMode Ltd
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simulta… Read more
InMode Ltd (INMD) - Net Assets
Latest net assets as of December 2025: $683.20 Million USD
Based on the latest financial reports, InMode Ltd (INMD) has net assets worth $683.20 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($766.43 Million) and total liabilities ($83.23 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $683.20 Million |
| % of Total Assets | 89.14% |
| Annual Growth Rate | 61.55% |
| 5-Year Change | 64.31% |
| 10-Year Change | N/A |
| Growth Volatility | 90.37 |
InMode Ltd - Net Assets Trend (2016–2025)
This chart illustrates how InMode Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for InMode Ltd (2016–2025)
The table below shows the annual net assets of InMode Ltd from 2016 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $683.20 Million | -2.93% |
| 2024-12-31 | $703.81 Million | -10.61% |
| 2023-12-31 | $787.37 Million | +41.97% |
| 2022-12-31 | $554.62 Million | +33.39% |
| 2021-12-31 | $415.80 Million | +62.76% |
| 2020-12-31 | $255.47 Million | +42.09% |
| 2019-12-31 | $179.80 Million | +302.46% |
| 2018-12-31 | $44.68 Million | +129.66% |
| 2017-12-31 | $19.45 Million | +113.30% |
| 2016-12-31 | $9.12 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to InMode Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 30608.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $968.53 Million | 141.76% |
| Total Equity | $683.20 Million | 100.00% |
InMode Ltd Competitors by Market Cap
The table below lists competitors of InMode Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771
|
$759.87 Million |
|
Blue Sail Medical Co Ltd
SHE:002382
|
$760.18 Million |
|
Bank of Xi'An Co Ltd
SHG:600928
|
$760.37 Million |
|
Yibin Tianyuan Group Co Ltd
SHE:002386
|
$760.40 Million |
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294
|
$759.54 Million |
|
J.S. Corrugating Machinery Co Ltd
SHE:000821
|
$759.53 Million |
|
Shanghai Zhenhua Heavy Industries Co Ltd B
SHG:900947
|
$759.20 Million |
|
Isracard Ltd
OTCGREY:ISCDF
|
$759.18 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in InMode Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 703,813,000 to 683,198,000, a change of -20,615,000 (-2.9%).
- Net income of 93,831,000 contributed positively to equity growth.
- Share repurchases of 127,444,000 reduced equity.
- Other comprehensive income increased equity by 340,000.
- Other factors increased equity by 12,658,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $93.83 Million | +13.73% |
| Share Repurchases | $127.44 Million | -18.65% |
| Other Comprehensive Income | $340.00K | +0.05% |
| Other Changes | $12.66 Million | +1.85% |
| Total Change | $- | -2.93% |
Book Value vs Market Value Analysis
This analysis compares InMode Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.25x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 80.27x to 1.25x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | $0.17 | $13.45 | x |
| 2017-12-31 | $0.30 | $13.45 | x |
| 2018-12-31 | $0.68 | $13.45 | x |
| 2019-12-31 | $2.31 | $13.45 | x |
| 2020-12-31 | $3.02 | $13.45 | x |
| 2021-12-31 | $4.83 | $13.45 | x |
| 2022-12-31 | $6.49 | $13.45 | x |
| 2023-12-31 | $9.16 | $13.45 | x |
| 2024-12-31 | $8.73 | $13.45 | x |
| 2025-12-31 | $10.78 | $13.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently InMode Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.73%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 25.33%
- • Asset Turnover: 0.48x
- • Equity Multiplier: 1.12x
- Recent ROE (13.73%) is below the historical average (29.85%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 3.77% | 1.46% | 1.40x | 1.85x | $-556.10K |
| 2017 | 45.33% | 16.50% | 1.36x | 2.03x | $6.87 Million |
| 2018 | 51.71% | 22.33% | 1.24x | 1.87x | $18.04 Million |
| 2019 | 34.73% | 39.11% | 0.72x | 1.24x | $43.54 Million |
| 2020 | 29.54% | 36.40% | 0.70x | 1.16x | $49.63 Million |
| 2021 | 39.68% | 46.14% | 0.75x | 1.15x | $123.39 Million |
| 2022 | 29.12% | 35.56% | 0.70x | 1.16x | $106.06 Million |
| 2023 | 25.14% | 40.22% | 0.57x | 1.10x | $119.18 Million |
| 2024 | 25.76% | 45.91% | 0.50x | 1.12x | $110.89 Million |
| 2025 | 13.73% | 25.33% | 0.48x | 1.12x | $25.51 Million |
Industry Comparison
This section compares InMode Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $498,972,584
- Average return on equity (ROE) among peers: -54.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| InMode Ltd (INMD) | $683.20 Million | 3.77% | 0.12x | $759.63 Million |
| Advanced Biomedical Technologies Inc (ABMT) | $-2.23 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $187.53 Billion |
| Acarix AB (publ) (ACIXF) | $51.88 Million | -150.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $19.91 Million | -270.00% | 1.43x | $3.82 Million |
| Adm Tronics Unltd (ADMT) | $644.00K | 0.00% | 0.66x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $6.03 Million | -94.15% | 0.22x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $75.02 Million | -52.81% | 0.78x | $732.88K |
| Adapthealth Corp (AHCO) | $24.31K | -2.84% | 11.78x | $916.00 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $9.37 Million | 23.33% | 0.30x | $8.41 Million |